Paper41982931
Design of permeability-optimized target-binding macrocycles via direct preference optimization.
Sun H and 5 others. Chem Sci, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Design of permeability-optimized target-binding macrocycles via direct preference optimization. Papers, record 41982931. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41982931
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Design of permeability-optimized target-binding macrocycles via direct preference optimization.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33467010 | Modulating Protein-Protein Interactions by Cyclic and Macrocyclic Peptides. Prominent Strategies and Examples. | Molecules | 2021 | https://conductscience.org/library/papers/33467010 | PubMed |
| 2 | 40406858 | HighPlay: Cyclic Peptide Sequence Design Based on Reinforcement Learning and Protein Structure Prediction. | J Med Chem | 2025 | https://conductscience.org/library/papers/40406858 | PubMed |
| 3 | 25038790 | How proteins bind macrocycles. | Nat Chem Biol | 2014 | https://conductscience.org/library/papers/25038790 | PubMed |
| 4 | 25591543 | Peptide therapeutics: targeting the undruggable space. | Eur J Med Chem | 2015 | https://conductscience.org/library/papers/25591543 | PubMed |
| 5 | 32875673 | Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development. | Chemistry | 2021 | https://conductscience.org/library/papers/32875673 | PubMed |
| 6 | 36041435 | Accurate de novo design of membrane-traversing macrocycles. | Cell | 2022 | https://conductscience.org/library/papers/36041435 | PubMed |
| 7 | 40542165 | Accurate de novo design of high-affinity protein-binding macrocycles using deep learning. | Nat Chem Biol | 2025 | https://conductscience.org/library/papers/40542165 | PubMed |
| 8 | 35763288 | Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritis. | Expert Rev Clin Pharmacol | 2022 | https://conductscience.org/library/papers/35763288 | PubMed |
| 9 | 17803196 | PAMPA--critical factors for better predictions of absorption. | J Pharm Sci | 2007 | https://conductscience.org/library/papers/17803196 | PubMed |
| 10 | 33510482 | Natural products in drug discovery: advances and opportunities. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33510482 | PubMed |
| 11 | 40877984 | Systematic benchmarking of 13 AI methods for predicting cyclic peptide membrane permeability. | J Cheminform | 2025 | https://conductscience.org/library/papers/40877984 | PubMed |
| 12 | 38155304 | De novo development of small cyclic peptides that are orally bioavailable. | Nat Chem Biol | 2024 | https://conductscience.org/library/papers/38155304 | PubMed |
| 13 | 39122750 | CREMP: Conformer-rotamer ensembles of macrocyclic peptides for machine learning. | Sci Data | 2024 | https://conductscience.org/library/papers/39122750 | PubMed |
| 14 | 30610225 | Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. | Nat Rev Drug Discov | 2019 | https://conductscience.org/library/papers/30610225 | PubMed |
| 15 | 30615063 | MMseqs2 desktop and local web server app for fast, interactive sequence searches. | Bioinformatics | 2019 | https://conductscience.org/library/papers/30615063 | PubMed |
| 16 | 23319623 | Buried lysine, but not arginine, titrates and alters transmembrane helix tilt. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23319623 | PubMed |
| 17 | 40824037 | Reinforcement Learning-Based Target-Specific De Novo Design of Cyclic Peptide Binders. | J Med Chem | 2025 | https://conductscience.org/library/papers/40824037 | PubMed |
| 18 | 33536635 | Trends in peptide drug discovery. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33536635 | PubMed |
| 19 | 22737969 | Intestinal permeability of cyclic peptides: common key backbone motifs identified. | J Am Chem Soc | 2012 | https://conductscience.org/library/papers/22737969 | PubMed |
| 20 | 26574392 | Long-Time-Step Molecular Dynamics through Hydrogen Mass Repartitioning. | J Chem Theory Comput | 2015 | https://conductscience.org/library/papers/26574392 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42957812 | Physicochemical rule-embedded generative modeling for constrained peptide therapeutics. | NPJ Drug Discov | 2026 | https://conductscience.org/library/papers/42957812 |
Source PubMed
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ISYNA1 | 51477 | PubTator's text mining | https://conductscience.org/library/genes/51477 | NCBI Gene |
| KEAP1 | 9817 | PubTator's text mining | https://conductscience.org/library/genes/9817 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
| SPSB2 | 84727 | PubTator's text mining | https://conductscience.org/library/genes/84727 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41982931
GET https://conductscience.org/api/papers/v1/41982931/references?page=2